Early Relapse after Autologous Hematopoietic Cell Transplantation remains a Poor Prognostic Factor in Multiple Myeloma but Outcomes Have Improved Over Time

Duration of initial disease response remains a strong prognostic factor in multiple myeloma (MM) particularly for upfront autologous hematopoietic cell transplant (AHCT) recipients. We hypothesized that new drug classes and combinations employed prior to AHCT as well as after post-AHCT relapse may h...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Shaji K, Dispenzieri, Angela, Fraser, Raphael, Mingwei, Fei, Akpek, Gorgun, Cornell, Robert, Kharfan-Dabaja, Mohamed, Freytes, Cesar, Hashmi, Shahrukh, Hildebrandt, Gerhard, Holmberg, Leona, Kyle, Robert, Lazarus, Hillard, Lee, Cindy, Mikhael, Joseph, Nishihori, Taiga, Tay, Jason, Usmani, Saad, Vesole, David, Vij, Ravi, Wirk, Baldeep, Krishnan, Amrita, Gasparetto, Cristina, Mark, Tomer, Nieto, Yago, Hari, Parameswaran, D’Souza, Anita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5871538/
https://www.ncbi.nlm.nih.gov/pubmed/29263438
http://dx.doi.org/10.1038/leu.2017.331

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5871538/
https://www.ncbi.nlm.nih.gov/pubmed/29263438
http://dx.doi.org/10.1038/leu.2017.331

Ejemplares similares